Farther Finance Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103 | Buy |
+9
| New | +$103 | ﹤0.01% | 4305 |
|
|
2025
Q1 | – | Sell |
-14
| Closed | -$264 | – | 4392 |
|
|
2024
Q4 | $264 | Hold |
14
| – | – | ﹤0.01% | 3587 |
|
|
2024
Q3 | $315 | Buy |
14
+5
| +56% | +$113 | ﹤0.01% | 3540 |
|
|
2024
Q2 | $188 | Hold |
9
| – | – | ﹤0.01% | 3505 |
|
|
2024
Q1 | $131 | Hold |
9
| – | – | ﹤0.01% | 3334 |
|
|
2023
Q4 | $93 | Buy |
+9
| New | +$93 | ﹤0.01% | 3309 |
|